In today’s briefing:
- Some updates
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
Some updates
- Recently Avrobio (AVRO) announced a reverse merger with Tectonic Therapeutic, which was a bit unexpected.
- And disappointing. From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive insiders.
- But I have no idea how to value this. Net cash will be <$1/share post merger so I am closing this with a small loss at $1.25.